chr7-105567208-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_021930.6(RINT1):c.2276C>T(p.Pro759Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00748 in 1,613,198 control chromosomes in the GnomAD database, including 59 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_021930.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RINT1 | NM_021930.6 | c.2276C>T | p.Pro759Leu | missense_variant | 15/15 | ENST00000257700.7 | NP_068749.3 | |
EFCAB10 | NM_001355526.2 | c.383+259G>A | intron_variant | ENST00000480514.6 | NP_001342455.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RINT1 | ENST00000257700.7 | c.2276C>T | p.Pro759Leu | missense_variant | 15/15 | 1 | NM_021930.6 | ENSP00000257700.2 | ||
EFCAB10 | ENST00000480514.6 | c.383+259G>A | intron_variant | 1 | NM_001355526.2 | ENSP00000418678.1 |
Frequencies
GnomAD3 genomes AF: 0.00525 AC: 799AN: 152212Hom.: 3 Cov.: 32
GnomAD3 exomes AF: 0.00545 AC: 1366AN: 250478Hom.: 3 AF XY: 0.00539 AC XY: 730AN XY: 135336
GnomAD4 exome AF: 0.00772 AC: 11276AN: 1460868Hom.: 56 Cov.: 30 AF XY: 0.00762 AC XY: 5540AN XY: 726698
GnomAD4 genome AF: 0.00524 AC: 798AN: 152330Hom.: 3 Cov.: 32 AF XY: 0.00472 AC XY: 352AN XY: 74500
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 02, 2020 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Benign, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The RINT1 p.Pro418Leu variant was not identified in the literature nor was it identified in Cosmic. The variant was identified in dbSNP (ID: rs34310648), ClinVar (classified as benign by Invitae), and LOVD 3.0. The variant was identified in control databases in 1493 of 267350 chromosomes (4 homozygous) at a frequency of 0.005584 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1, non-cancer). The variant was observed in the following populations: Ashkenazi Jewish in 149 of 9852 chromosomes (freq: 0.01512), European (non-Finnish) in 995 of 117934 chromosomes (freq: 0.008437), Other in 50 of 6678 chromosomes (freq: 0.007487), South Asian in 133 of 30174 chromosomes (freq: 0.004408), European (Finnish) in 64 of 25096 chromosomes (freq: 0.00255), Latino in 69 of 34774 chromosomes (freq: 0.001984) and African in 33 of 23618 chromosomes (freq: 0.001397), but was not observed in the East Asian population. The p.Pro418 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign. - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | EFCAB10: BS2; RINT1: BP4, BS2 - |
RINT1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 01, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at